近年来，受到多重因素共同影响，脱发问题已经从小众群体的焦虑演变为受到广泛关注的健康问题。公开数据显示，2024年 我国有超过3.39亿人受脱发问题困扰，其中超过60%年龄在35岁以下。 "秃"如其来的烦恼扩大化、年轻化，这对于为市场提供治疗脱发产品的公司而言无疑是一个确定性的成长机遇。智通财经注 意到，日前，率先推出蔓迪米诺地尔类产品的蔓迪国际向港交所主板递交了上市申请。招股书显示，蔓迪国际早在2001年便 在国内获批了首款5%米诺地尔酊剂产品，并以蔓迪为品牌，填补了国内脱发治疗市场的关键空白。2018-2024年，蔓迪国际 的蔓迪系列米诺地尔类产品的销量总计超过5000万瓶。另按销售额计算，该公司的蔓迪系列米诺地尔类产品自2014年起连续 十年位居中国脱发药物市场第一。 在头发健康领域显然已占据了先发优势与规模优势的蔓迪国际，如今正式向资本市场发起冲刺。公司的基本面成色究竟如 何？展望未来，蔓迪国际的成长性能否令二级市场里挑剔的投资者们满意？关于这些问题，透过公司的招股书，或许能窥见 一二。 强劲的盈利能力，同样是蔓迪国际基本面的突出特征之一。报告期内，蔓迪国际的毛利分别为7.89亿元、10.07亿元、12 ...

Core Viewpoint - JD Internet Hospital has launched a dermatology beauty and skincare clinic, focusing on skin issues for individuals aged 15 to 55, leveraging top-tier hospital resources and AI skin analysis technology to provide a comprehensive skin health management solution [2][3]. Group 1: Service Offering - The clinic addresses various skin concerns including acne, scars, spots, wrinkles, sores, and moles, providing professional and convenient services [2]. - Users can access the service through the JD APP, with top-tier hospital doctors available online 24/7, averaging a 30-second response time for consultations [2]. Group 2: Industry Context - The medical beauty industry in China is rapidly growing, with increasing consumer trends towards beauty and aesthetic treatments, although issues such as excessive marketing and unregulated practices persist [2]. - JD Internet Hospital aims to mitigate these issues by offering scientifically backed medical advice and helping users assess their aesthetic needs rationally [2][3]. Group 3: Technological Integration - The clinic integrates AI skin analysis tools developed by JD Health, utilizing extensive medical dialogue data and a vast image database to analyze skin issues across five dimensions, generating visual reports for users [3]. - After analysis, the system matches users with dermatology experts from top-tier hospitals for personalized consultations and treatment recommendations [3]. Group 4: Strategic Goals - JD Internet Hospital has been focusing on dermatology for years, aiming to provide refined and personalized treatment options by integrating top medical resources and technological capabilities [4].